Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report
Pharmacogenomics and Personalized Medicine · 2026-04 · Volume 19 · 1-11
DOI: 10.2147/pgpm.s578577 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pharmacogenomics and Personalized Medicine, 2026-04. Verfasst von Ruoxiang Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.
- Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.
- Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Nanning, People's Republic of China.
- Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.
ORCID-Profile: Xiwen Liao, Chengkun Yang, Tao Peng
Zitieren
APA
Xu, R., Zhang, M., Zeng, Z., Wei, Y., Liao, X., Yang, C., Peng, T., & Su, H. (2026). Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report. Pharmacogenomics and Personalized Medicine, Volume 19, 1-11. https://doi.org/10.2147/pgpm.s578577
Vancouver
Xu R, Zhang M, Zeng Z, Wei Y, Liao X, Yang C, et al. Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report. Pharmacogenomics and Personalized Medicine. 2026;Volume 19:1-11. doi:10.2147/pgpm.s578577
BibTeX
@article{Xu2026,
author = {Xu, Ruoxiang and Zhang, Mingrui and Zeng, Zhiming and Wei, Yongguang and Liao, Xiwen and Yang, Chengkun and Peng, Tao and Su, Hao},
title = {Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report},
journal = {Pharmacogenomics and Personalized Medicine},
year = {2026},
volume = {Volume 19},
pages = {1--11},
doi = {10.2147/pgpm.s578577}
}
EUVIMED